MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

Sporadic Alzheimer's disease (AD) is the most prevalent form of dementia, but no clear disease‐initiating mechanism is known. Aβ deposits and neuronal tangles composed of hyperphosphorylated tau are characteristic for AD. Here, we analyze the contribution of microRNA‐125b (miR‐125b), which is elevated in AD. In primary neurons, overexpression of miR‐125b causes tau hyperphosphorylation and an upregulation of p35, cdk5, and p44/42‐MAPK signaling. In parallel, the phosphatases DUSP6 and PPP1CA and the anti‐apoptotic factor Bcl‐W are downregulated as direct targets of miR‐125b. Knockdown of these phosphatases induces tau hyperphosphorylation, and overexpression of PPP1CA and Bcl‐W prevents miR‐125b‐induced tau phosphorylation, suggesting that they mediate the effects of miR‐125b on tau. Conversely, suppression of miR‐125b in neurons by tough decoys reduces tau phosphorylation and kinase expression/activity. Injecting miR‐125b into the hippocampus of mice impairs associative learning and is accompanied by downregulation of Bcl‐W, DUSP6, and PPP1CA, resulting in increased tau phosphorylation in vivo. Importantly, DUSP6 and PPP1CA are also reduced in AD brains. These data implicate miR‐125b in the pathogenesis of AD by promoting pathological tau phosphorylation.

[1]  P. Rudrabhatla,et al.  Role of protein phosphatase 2A in Alzheimer's disease. , 2011, Current Alzheimer research.

[2]  A. Roses,et al.  O3-02-07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways , 2008, Alzheimer's & Dementia.

[3]  T. Ohm.  The dentate gyrus in Alzheimer's disease. , 2007, Progress in brain research.

[4]  F. Sohrabji,et al.  An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model , 2012, PloS one.

[5]  Luc Buée,et al.  Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. , 2010, Human molecular genetics.

[6]  Hong Shi,et al.  MiR-125b Inhibits Tumor Growth and Promotes Apoptosis of Cervical Cancer Cells by Targeting Phosphoinositide 3-Kinase Catalytic Subunit Delta , 2012, Cellular Physiology and Biochemistry.

[7]  B. Winblad,et al.  Assessments of the accumulation severities of amyloid β-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains , 2006, Neurobiology of Disease.

[8]  K. Imahori,et al.  Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β , 1996, Neuroscience Letters.

[9]  Hyoung-Gon Lee,et al.  Neuroprotective properties of Bcl‐w in Alzheimer disease , 2004, Journal of neurochemistry.

[10]  R. Tanzi.  The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[11]  L. Tsai,et al.  Cyclin-dependent kinases in brain development and disease. , 2011, Annual review of cell and developmental biology.

[12]  J. Roh,et al.  miR‐206 regulates brain‐derived neurotrophic factor in Alzheimer disease model , 2012, Annals of neurology.

[13]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[14]  A. van Oudenaarden,et al.  MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. , 2007, Molecular cell.

[15]  M. Sur,et al.  miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. , 2011, Nature neuroscience.

[16]  Aikaterini S. Papadopoulou,et al.  Alteration of the microRNA network during the progression of Alzheimer's disease , 2013, EMBO molecular medicine.

[17]  T. Preiss,et al.  Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.

[18]  R. D'Hooge,et al.  Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission , 2011, Neurobiology of Learning and Memory.

[19]  K. Imahori,et al.  Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Lukiw,et al.  microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.

[21]  Michael T. McManus,et al.  Dicer ablation in oligodendrocytes provokes neuronal impairment in mice , 2009, Annals of neurology.

[22]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[23]  I. Prior,et al.  Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells. , 2010, The Biochemical journal.

[24]  P. Sharp,et al.  Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125 b and miR-132 , 2010 .

[25]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[26]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[27]  Emma R. Wood,et al.  The role of hippocampal subregions in memory for stimulus associations , 2010, Behavioural Brain Research.

[28]  Nancy M Bonini,et al.  MicroRNAs and neurodegeneration: role and impact. , 2013, Trends in cell biology.

[29]  Walter J. Lukiw,et al.  Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.

[30]  S. Willimott,et al.  miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells* , 2011, The Journal of Biological Chemistry.

[31]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[32]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[33]  C. Print,et al.  Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine , 2000, Oncogene.

[34]  E. Nishida,et al.  ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 , 2001, Nature Cell Biology.

[35]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[36]  P. Falkai,et al.  microRNA‐34c is a novel target to treat dementias , 2011, The EMBO journal.

[37]  M. Sheng,et al.  Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Ras-ERK Signaling and AMPA Receptor Trafficking , 2005, Neuron.

[38]  J. Mattick,et al.  MicroRNA regulation of neural plasticity and memory , 2011, Neurobiology of Learning and Memory.

[39]  M. Janitz,et al.  Transcriptome profiling in neurodegenerative disease , 2010, Journal of Neuroscience Methods.

[40]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.

[41]  F. Agani,et al.  Reactive oxygen species regulate ERBB 2 and ERBB 3 expression via miR-199 a / 125 b and DNA methylation , 2013 .

[42]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[43]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[44]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.

[45]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[46]  D. Edbauer,et al.  Good guy or bad guy: the opposing roles of microRNA 125b in cancer , 2014, Cell Communication and Signaling.

[47]  F. Agani,et al.  Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR‐199a/125b and DNA methylation , 2012, EMBO reports.

[48]  A. Borczuk,et al.  Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. , 2010, Carcinogenesis.

[49]  B. Li,et al.  MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R , 2013, Oncogene.

[50]  S. Hébert,et al.  Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers , 2013, Front. Mol. Neurosci..

[51]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[52]  J. Lambert,et al.  Drosophila Models of Tauopathies: What Have We Learned? , 2012, International journal of Alzheimer's disease.

[53]  C. Haass,et al.  Loss of fused in sarcoma (FUS) promotes pathological Tau splicing , 2012, EMBO reports.

[54]  I. Módy,et al.  Deletion of Astroglial Dicer Causes Non-Cell-Autonomous Neuronal Dysfunction and Degeneration , 2011, The Journal of Neuroscience.

[55]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[56]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[57]  S V Faraone,et al.  Genetics of Alzheimer's disease. , 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.

[58]  L. Buée,et al.  MicroRNAs and the Regulation of Tau Metabolism , 2012, International journal of Alzheimer's disease.

[59]  Jianhua Shi,et al.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[60]  S. Hébert,et al.  Alterations of the microRNA network cause neurodegenerative disease , 2009, Trends in Neurosciences.

[61]  J. Lieberman,et al.  Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs , 2011, PLoS genetics.

[62]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[63]  H. Iba,et al.  Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells , 2009, Nucleic acids research.

[64]  J. Denu,et al.  Intramolecular dephosphorylation of ERK by MKP3. , 2003, Biochemistry.

[65]  Anna M. Krichevsky,et al.  MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons , 2013, The Journal of Neuroscience.

[66]  Sun-Chong Wang,et al.  Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease , 2008, PloS one.

[67]  Y. Y. Li,et al.  Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation , 2010, Neuroscience Letters.

[68]  Cornelia M. Wilson,et al.  Tau protein kinases: Involvement in Alzheimer's disease , 2013, Ageing Research Reviews.